Well I dont think ivermectin (which wasnt effective enough) nor potentially MPL would be a once in a lifetime treatment.
Im going on a wild assumption that people may be hit with viruses such as covid many many timea throughout their lives....and so a treatment would be required many times?
But yes im sure it was pfizer and co that prevented PAA going to human trials on covid, rather than perhaps an internal business decision around resource prioritisation, risk management etc...
MY INPUT REGARDING PAA AND SARS-COV-2., page-41
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.015(6.25%) |
Mkt cap ! $109.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.5¢ | $133.9K | 573.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 303213 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 57592 | 2 |
View Market Depth
| Last trade - 15.46pm 18/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |